Estimating the incidence of endophthalmitis using a national medical database

Ophthalmic Epidemiology

Volumn 15, Issue 6, 2008, Pages 357-358

  Gower, Emily W ^a,b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b 116 Wilmer Building ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFUROXIME; CEPHALOSPORIN; LEVOFLOXACIN; MOXIFLOXACIN; PENICILLIN G;

ANTIBIOTIC PROPHYLAXIS; CATARACT EXTRACTION; CLINICAL TRIAL; DATA BASE; EDITORIAL; ENDOPHTHALMITIS; HUMAN; INCIDENCE; ITALY; MEDICAL PRACTICE; POPULATION RESEARCH; PRIORITY JOURNAL; SURGEON;

DATABASES, FACTUAL; ENDOPHTHALMITIS; HUMANS; INCIDENCE; ITALY; POPULATION SURVEILLANCE;

EID: 57449099916     PISSN: 09286586     EISSN: 17445086     Source Type: Journal    
DOI: 10.1080/09286580802624459     Document Type: Editorial

References (6)

1. Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors. J Cataract Refract Surg. 2007;33:978-988.
2. Lundstrom M, Wejde G, Stenevi U, Thorburn W, Montan P. Endophthalmitis after cataract surgery: a nationwide prospective study evaluating incidence in relation to incision type and location. Ophthalmology. 2007;114:866-870.
3. Chang DF, et al. Prophylaxis of postoperative endophthalmitis after cataract surgery: results of the 2007 ASCRS member survey. J Cataract Refract Surg. 2007;33:1801-1805.
4. Lane SS, Osher RH, Masket S, Belani S. Evaluation of the safety of prophylactic intracameral moxifloxacin in cataract surgery. J Cataract Refract Surg. 2008;34:1451-1459.
5. Arbisser LB. Safety of intracameral moxifloxacin for prophylaxis of endophthalmitis after cataract surgery. J Cataract Refract Surg. 2008;34:1114-1120.
6. Espiritu CR, Caparas VL, Bolinao JG. Safety of prophylactic intracameral moxifloxacin 0.5% ophthalmic solution in cataract surgery patients. J Cataract Refract Surg. 2007;33:63-68.